Organization (Other)
Ludwig Boltzmann Gesellschaft
ClinicalTrials.gov lists Ludwig Boltzmann Gesellschaft as lead sponsor of 23 trials, counting the companies grouped under it. Ludwig Boltzmann Gesellschaft itself has 2 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers Ludwig Boltzmann Gesellschaft and 6 companies grouped under it: 23 lead-sponsored trials (7 its own, 16 in the grouped companies) and 7 legal-entity registrations (1 its own, 6 in the grouped companies).
Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.
Companies grouped under this page (6)
Shown in this order: most lead trials first.
| Company | Lead trials | Legal entities |
|---|---|---|
| Ludwig Boltzmann Institute for Digital Health and Prevention | 7 | 1 |
| Ludwig Boltzmann Institute for Lung Health | 4 | 1 |
| Ludwig Boltzmann Institute for Traumatology, The Research Center in Cooperation with AUVA | 2 | 1 |
| Ludwig Boltzmann Institute for Arthritis and Rehabilitation | 1 | 1 |
| Ludwig Boltzmann Institute for Cardiovascular Research | 1 | 1 |
Showing 5 of 6 member companies.
Disease areas (40)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Hypertension, Pulmonary | 8 |
| Hypertension | 6 |
| Heart Arrest | 4 |
| Pulmonary Disease, Chronic Obstructive | 4 |
| Inflammation | 3 |
Showing 5 of 40 disease areas.
Trials by start year as sponsor or collaborator (8)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2025 | 1 |
| 2021 | 1 |
| 2017 | 2 |
| 2015 | 1 |
| 2013 | 1 |
| 2012 | 2 |
| 2011 | 1 |
| 2007 | 2 |
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (2)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Milrinone | 1 |
| DONEPEZIL | 1 |
Journals published in (69)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Circulation | 4 |
| Critical care medicine | 4 |
| European journal of translational myology | 4 |
| Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies | 4 |
| BMJ open | 3 |
Showing 5 of 69 journals.
Organization relationships (5)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Medical University of Graz | Co sponsors trial with | 2 |
| Semmelweis University | Co sponsors trial with | 1 |
| Paracelsus Medical University | Co sponsors trial with | 1 |
| Salzburger Landeskliniken | Co sponsors trial with | 1 |
| Sigmund Freud PrivatUniversitat | Co sponsors trial with | 1 |
Latest dated events (54)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2027-06-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-09-03 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-09-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-08-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 54 events.
Biomarkers this organization publishes on (176)
Shown in this order: most publications first.
Showing 5 of 176 biomarkers.
Not on this page
Checked, with nothing recorded for this organization: active development programs, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.